These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 32379529)

  • 1. Technical Considerations for Use of Oligonucleotide Solution API.
    Muslehiddinoglu J; Simler R; Hill ML; Mueller C; Amery JHA; Dixon L; Watson A; Storch K; Gazziola C; Gielen F; Lange SA; Prail JD; Nesta DP
    Nucleic Acid Ther; 2020 Aug; 30(4):189-197. PubMed ID: 32379529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Solution Oligonucleotide APIs: Regulatory Considerations.
    Wetter C; Chorley C; Curtis C; Del Canto N; Ford JG; Franklin J; Gazziola C; Jones MT; Lee J; McAuley A; Saraber FCE; Scott A; Tom J
    Ther Innov Regul Sci; 2022 May; 56(3):386-393. PubMed ID: 35133632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integration of active pharmaceutical ingredient solid form selection and particle engineering into drug product design.
    Ticehurst MD; Marziano I
    J Pharm Pharmacol; 2015 Jun; 67(6):782-802. PubMed ID: 25677227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simplified end-to-end continuous manufacturing by feeding API suspensions in twin-screw wet granulation.
    Schmidt A; de Waard H; Moll KP; Kleinebudde P; Krumme M
    Eur J Pharm Biopharm; 2018 Dec; 133():224-231. PubMed ID: 30291963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Case Study in the Design of a Surrogate Solution for Use in Biopharmaceutical Drug Product Process Development.
    Boksa K; Walsh P; Shah A
    AAPS PharmSciTech; 2021 Jan; 22(1):32. PubMed ID: 33404995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An example of how to handle amorphous fractions in API during early pharmaceutical development: SAR114137--a successful approach.
    Petzoldt C; Bley O; Byard SJ; Andert D; Baumgartner B; Nagel N; Tappertzhofen C; Feth MP
    Eur J Pharm Biopharm; 2014 Apr; 86(3):337-50. PubMed ID: 24075979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Practical aspects of lyophilization using non-aqueous co-solvent systems.
    Teagarden DL; Baker DS
    Eur J Pharm Sci; 2002 Mar; 15(2):115-33. PubMed ID: 11849908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Manufacturing of solid dispersions of poorly water soluble drugs by spray drying: formulation and process considerations.
    Paudel A; Worku ZA; Meeus J; Guns S; Van den Mooter G
    Int J Pharm; 2013 Aug; 453(1):253-84. PubMed ID: 22820134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Raw material variability of an active pharmaceutical ingredient and its relevance for processability in secondary continuous pharmaceutical manufacturing.
    Stauffer F; Vanhoorne V; Pilcer G; Chavez PF; Rome S; Schubert MA; Aerts L; De Beer T
    Eur J Pharm Biopharm; 2018 Jun; 127():92-103. PubMed ID: 29452241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thiol-disulfide exchange in peptides derived from human growth hormone during lyophilization and storage in the solid state.
    Chandrasekhar S; Topp EM
    J Pharm Sci; 2015 Apr; 104(4):1291-302. PubMed ID: 25631887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spray Encapsulation as a Formulation Strategy for Drug-Based Room Temperature Ionic Liquids: Exploiting Drug-Polymer Immiscibility to Enable Processing for Solid Dosage Forms.
    Stocker MW; Healy AM; Ferguson S
    Mol Pharm; 2020 Sep; 17(9):3412-3424. PubMed ID: 32852215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of stable lyophilized protein drug products.
    Remmele RL; Krishnan S; Callahan WJ
    Curr Pharm Biotechnol; 2012 Mar; 13(3):471-96. PubMed ID: 22283723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Practical Considerations for Determination of Glass Transition Temperature of a Maximally Freeze Concentrated Solution.
    Pansare SK; Patel SM
    AAPS PharmSciTech; 2016 Aug; 17(4):805-19. PubMed ID: 27193003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel co-processing method to manufacture an API for extended release formulation via formation of agglomerates of active ingredient and hydroxypropyl methylcellulose during crystallization.
    Rosenbaum T; Erdemir D; Chang SY; Kientzler D; Wang S; Chan SH; Brown J; Hanley S; Kiang S
    Drug Dev Ind Pharm; 2018 Oct; 44(10):1606-1612. PubMed ID: 29916275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Freeze-drying of nanoparticles: formulation, process and storage considerations.
    Abdelwahed W; Degobert G; Stainmesse S; Fessi H
    Adv Drug Deliv Rev; 2006 Dec; 58(15):1688-713. PubMed ID: 17118485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physical characterization of pharmaceutical formulations in frozen and freeze-dried solid states: techniques and applications in freeze-drying development.
    Liu J
    Pharm Dev Technol; 2006 Feb; 11(1):3-28. PubMed ID: 16544906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Manufacturing of High-Concentration Monoclonal Antibody Formulations via Spray Drying-the Road to Manufacturing Scale.
    Gikanga B; Turok R; Hui A; Bowen M; Stauch OB; Maa YF
    PDA J Pharm Sci Technol; 2015; 69(1):59-73. PubMed ID: 25691715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Finite Element Method (FEM) Modeling of Freeze-drying: Monitoring Pharmaceutical Product Robustness During Lyophilization.
    Chen X; Sadineni V; Maity M; Quan Y; Enterline M; Mantri RV
    AAPS PharmSciTech; 2015 Dec; 16(6):1317-26. PubMed ID: 25791415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combining Isolation-Free and Co-Processing Manufacturing Approaches to Access Room Temperature Ionic Liquid Forms of APIs.
    Stocker MW; Tsolaki E; Harding MJ; Healy AM; Ferguson S
    J Pharm Sci; 2023 Aug; 112(8):2079-2086. PubMed ID: 36806585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lyophilization of Small-Molecule Injectables: an Industry Perspective on Formulation Development, Process Optimization, Scale-Up Challenges, and Drug Product Quality Attributes.
    Butreddy A; Dudhipala N; Janga KY; Gaddam RP
    AAPS PharmSciTech; 2020 Sep; 21(7):252. PubMed ID: 32885357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.